De Sheng Tao
Direktor/Vorstandsmitglied bei LIVZON PHARMACEUTICAL GROUP INC.
Vermögen: 5 Mio $ am 30.04.2024
Aktive Positionen von De Sheng Tao
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LIVZON PHARMACEUTICAL GROUP INC. | Direktor/Vorstandsmitglied | 01.07.2009 | - |
| Corporate Officer/Principal | 01.06.2005 | 10.03.2014 | |
| Präsident | 01.01.1985 | 28.12.2018 | |
Zhuhai Livzon Diagnostics, Inc.
 Zhuhai Livzon Diagnostics, Inc. Medical SpecialtiesHealth Technology Zhuhai Livzon Diagnostics, Inc. engages in the development, production, and marketing of in-vitro diagnostic (IVD) products. Its products include diagnostic kit for Immunoglobulin M (IgM) / Immunoglobulin G (IgG) antibody to coronavirus (SARS-CoV-2), autoimmunity multiple detection platform, chemiluminescence detection platform, nucleic acid molecule detection platform, and X-ray blood irradiator. The company was founded on January 26, 1989 and is headquartered in Zhuhai, China. | Vorsitzender | 05.05.2014 | - |
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1979, Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. is a subsidiary of Livzon Pharmaceutical Group, Inc. The company is based in Fuzhou, China and manufactures and sells pharmaceutical products. | Direktor/Vorstandsmitglied | - | - |
ZHU HAI Livzon Biologics Ltd.
 ZHU HAI Livzon Biologics Ltd. Pharmaceuticals: MajorHealth Technology LivzonBio, Inc. engages in the research, development, production, and sale of pharmaceutical products as well as pharmaceutical technology development, transfer, consultation, and related technical services. The company was founded on November 23, 2017 and is headquartered in Zhuhai, China. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von De Sheng Tao
Ausbildung von De Sheng Tao
| China Pharmaceutical University | Undergraduate Degree |
Statistik
International
| China | 6 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 1 |
| President | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LIVZON PHARMACEUTICAL GROUP INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Zhuhai Livzon Diagnostics, Inc.
Zhuhai Livzon Diagnostics, Inc. Medical SpecialtiesHealth Technology Zhuhai Livzon Diagnostics, Inc. engages in the development, production, and marketing of in-vitro diagnostic (IVD) products. Its products include diagnostic kit for Immunoglobulin M (IgM) / Immunoglobulin G (IgG) antibody to coronavirus (SARS-CoV-2), autoimmunity multiple detection platform, chemiluminescence detection platform, nucleic acid molecule detection platform, and X-ray blood irradiator. The company was founded on January 26, 1989 and is headquartered in Zhuhai, China. | Health Technology |
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1979, Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. is a subsidiary of Livzon Pharmaceutical Group, Inc. The company is based in Fuzhou, China and manufactures and sells pharmaceutical products. | Health Technology |
ZHU HAI Livzon Biologics Ltd.
ZHU HAI Livzon Biologics Ltd. Pharmaceuticals: MajorHealth Technology LivzonBio, Inc. engages in the research, development, production, and sale of pharmaceutical products as well as pharmaceutical technology development, transfer, consultation, and related technical services. The company was founded on November 23, 2017 and is headquartered in Zhuhai, China. | Health Technology |
- Börse
- Insiders
- De Sheng Tao
- Erfahrung
